Miro Viitala - UTU Research Portal

Miro Viitala

MediCity (Faculty of Medicine)

mikavii@utu.fi

Publications

LINC01871 is exclusively expressed in T and NK cells and is highly induced upon CD4+ T cell activation (2025)
- iScience
Kalim, Ubaid Ullah; Shetty, Ankitha; Ranade, Amogh; Rundquist, Olof; Starskaia, Inna; Batkulwar, Kedar; Välikangas, Tommi; Sousa, António G. G.; Hurme, Antti; Kumpulainen, Venla; Viitala, Miro; Kosola, Sakari; Junttila, Sini; Rasool, Omid; Elo, Laura L.; Galande, Sanjeev; Lahesmaa, Riitta
(A1 Refereed original research article in a scientific journal)
Secreted Clever-1 modulates T cell responses and impacts cancer immunotherapy efficacy (2025)
- Theranostics
Prince, Stuart; Viitala, Miro; Sjoroos, Riikka; Bendes, Abris a.; Rannikko, Jenna H.; Patten, Daniel A.; di Benedetto, Ilaria; Turpin, Rita; Ylitalo, Arno; Tyni, Laura; Figueiredo, Carlos R.; Bostrom, Pia; Koskivuo, Ilkka; Salminen, Tiina A.; Shetty, Shishir; Hollmen, Maija
(A1 Refereed original research article in a scientific journal)
A form of inherited hyperferritinemia associated with bi-allelic pathogenic variants of STAB1 (2023)
- American Journal of Human Genetics
Monfrini Edoardo, Pelucchi Sara, Hollmén Maija, Viitala Miro, Mariani Raffaella, Bertola Francesca, Majore Silvia, Fonzo Alessio D, Piperno Alberto
(A1 Refereed original research article in a scientific journal)
Makrofagit älykkäästi mukaan syövän hoitoon (2023)
- Duodecim
Viitala Miro, Hollmén Maija
(A2 Refereed review article in a scientific journal )
Re-educating macrophages to activate antitumor immunity: One Clever Immunotherapy (2023) Viitala Miro
(G5 Article dissertation )
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial (2021)
- Clinical Cancer Research
Virtakoivu Reetta, Rannikko Jenna H, Viitala Miro, Vaura Felix, Takeda Akira, Lönnberg Tapio, Koivunen Jussi, Jaakkola Panu, Pasanen Annika, Shetty Shishir, de Jonge Maja JA, Robbrecht Debbie, Ma Yuk Ting, Skyttä Tanja, Minchom Anna, Jalkanen Sirpa, Karvonen Matti K, Mandelin Jami, Bono Petri, Hollmén Maija
(A1 Refereed original research article in a scientific journal)
Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8(+) T-cell Response against Immunosuppressive Tumors (2019)
- Clinical Cancer Research
Viitala M., Virtakoivu R., Tadayon S., Rannikko J., Jalkanen S., Hollmen M.
(A1 Refereed original research article in a scientific journal)
Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice (2018)
- Frontiers in immunology
Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmen M, Jalkanen S, Salmi M
(A1 Refereed original research article in a scientific journal)
Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice (2018)
- Arteriosclerosis, Thrombosis, and Vascular Biology
Petteri Rinne, James J. Kadiri, Mauricio Velasco-Delgado, Salla Nuutinen, Miro Viitala, Maija Hollmén, Martina Rami, Eriika Savontaus, Sabine Steffens
(A1 Refereed original research article in a scientific journal)
High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer (2016)
- Journal of Molecular Biochemistry
Kirsi Ketola, Miro Viitala, Pekka Kohonen, Vidal Fey, Zoran Culig, Olli Kallioniemi, Kristiina Iljin
(A1 Refereed original research article in a scientific journal)